期刊文献+

Determination of metronidazole in a rat stomach by HPLC for obtaining basic data of the eradication therapy of Helicobacter pylori 被引量:1

Determination of metronidazole in a rat stomach by HPLC for obtaining basic data of the eradication therapy of Helicobacter pylori
下载PDF
导出
摘要 In the eradication therapy of Helicobacter pylori changes of antibiotics as these concentrations or amount in the stomach after oral administration were not clear. A simple and accurate method for determining the concentration of metronidazole (MTZ) in homogenate of rat stomach was developed in order to obtain basic data to design a pharmaceutical preparation having targeting ability to the surface of gastric-mucosa. This method included a deproteinization process by methanol, separation with reversed-phase high-performance liquid chromatography, and detection with an ultraviolet wavelength of 370 nm. Regression analysis showed that the method was linear over a standard curve nmge from 5 ug/mL to 2000 g/mL. The inter-day precision and accuracy values between thc ranges were 5.0% or better and -7.5 to 5.2%, respectively. The newly developed method was applied to an analysis of gastric samples after oral administration of MTZ at a dose of 5 mg/kg. It was found that the residual MTZ in the stomach was determined within 5 h after dosing. This method is useful for monitoring MTZ in stomach after its oral administration to rats. In the eradication therapy of Helicobacter pylori changes of antibiotics as these concentrations or amount in the stomach after oral administration were not clear. A simple and accurate method for determining the concentration of metronidazole (MTZ) in homogenate of rat stomach was developed in order to obtain basic data to design a pharmaceutical preparation having targeting ability to the surface of gastric-mucosa. This method included a deproteinization process by methanol, separation with reversed-phase high-performance liquid chromatography, and detection with an ultraviolet wavelength of 370 nm. Regression analysis showed that the method was linear over a standard curve nmge from 5 ug/mL to 2000 g/mL. The inter-day precision and accuracy values between thc ranges were 5.0% or better and -7.5 to 5.2%, respectively. The newly developed method was applied to an analysis of gastric samples after oral administration of MTZ at a dose of 5 mg/kg. It was found that the residual MTZ in the stomach was determined within 5 h after dosing. This method is useful for monitoring MTZ in stomach after its oral administration to rats.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2012年第5期378-381,共4页 药物分析学报(英文版)
关键词 METRONIDAZOLE HPLC HOMOGENATE STOMACH RAT Metronidazole HPLC Homogenate Stomach Rat
  • 相关文献

参考文献14

  • 1A. Ateshkadi, N.P. Lam, C.A. Johnson, Helicobacter pylori and peptic ulcer disease, Clin. Pharm. 12 (1993) 34-48.
  • 2A.T. Axon, Helicobacter pylori therapy: effect on peptic ulcer disease, J. Gastroenterol. Hepatol. 6 (1991) 131-137.
  • 3P.O. Erah, A.F. Goddard, D.A. Barrett, et al., The stability of amoxicillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection, Antimicrob. Agents Chemother. 39 (1997) 5 12.
  • 4H. Katayama, T. Nishimura, S. Oclai, et al., Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pylori, Biol. Pharm. Bull. 22 (1999) 55-60.
  • 5M. Hatakeyama, Oncogenic mechanism of Helicobacter.pylori, Jap. J. Clin. Immunol. 3l (2008) 132-140.
  • 6N. Ohrlishi, H. Yuasa, S. Tanaka, et al., Transgenic expression of Helicobacter.pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse, Proc. Natl. Acad. Sci. USA 105 (2008) 10091008.
  • 7R.H. Argent, M. Kidd, R.J. Owen, et al., Determinats and con- sequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter.pylori, Gastroenterol. 127 (2004) 669672.
  • 8T. Fujioka, A. Yoshiiwa, T. Okimoto, et al., Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects, J. Gastroenterol. 42 (2007) 3-6.
  • 9M.P. Cooreman, P. Krausgrill, K.J. Hengels, Local gastric and serum amoxicillin concentration after different oral application forms, Antimicrob. Agents Chemother. 37 (1993) 1506 1509.
  • 10M. Kubodera, T. Tokumura, Y. Machida, Are the optimum pharmaceutical preparations used for the second-line eradication therapy for Helicobacter pylori infection in Japan? A discussion from a simulation for the amount of antibiotics in stomach based on the data of dissolution studies, J. Basic Clin. Pharm. 1 (2010) 231-237.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部